Clinical Trial

ULtrafiltration-Rate Induced CArdiac Strain (ULRICA) - Study

Study acronym: ULRICA
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 16, 2024 (before its estimated March 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Patients performing chronic hemodialysis (HD) retain more or less water between dialyses. The water is removed by ultrafiltration and usually during the cleansing of waste products - the HD. The length of HD is usually the same as the time of fluid removal while sometimes this may differ. There is no clear guideline. In previous research the investigator noted that the heart releases more NT-pro-BNP during HD in numerous of the patients. The present study aims to clarify if the speed of fluid removal during HD is a factor that may alter the release of cardiac markers during HD. If so the recommendations for the prescription of HD can be updated.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-11-22; most recent amendment 2024-12-10.
Trial Details
NCT Number NCT06153888
Lead Sponsor Umeå University
Conditions Fluid Overload, Dialysis; Complications
Enrollment 40 participants
Start Date 2023-03-20
Primary Completion 2026-03-30 (estimated)
Study Completion 2026-04-30 (estimated)
Updated on ClinicalTrials.gov 2024-12-16